InsiderInsights.com Daily Round Up 1/9/15: OAS, OPK, RM, VVUS

|
Includes: BBY, BRT, CLNY, CRDS, CRM, CUDA, GEVA, OAS, OPK, PATK, RFP, RM, SVU, UNFI, VGEN, VVUS, WIW, WYY
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on 1/9/15, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history. Also feel free to email us with any questions on our proprietary insider data, Insider Filer Statistics, and Insider Company Ratings.

On Today's Tables:

Insider trades were rated Significant at:

  • Regional Mgt (NYSE:RM);
  • Opko Health (NYSEMKT:OPK), and;
  • Oasis Petroleum (NYSE:OAS).

Insider trades were rated Nearly Significant at:

  • WAC Inf-linked Opp (NYSE:WIW);
  • WidePoint (NYSEMKT:WYY);
  • Vivus (NASDAQ:VVUS), and;
  • BRT Realty Trust (NYSE:BRT).

Insider trades were considered Insignificant at:

  • Vaccinogen (OTCQB:VGEN);
  • Supervalu (NYSE:SVU);
  • Crossroads Sys (NASDAQ:CRDS);
  • United Natural Foods (NASDAQ:UNFI);
  • Resolute Forest (NYSE:RFP);
  • Patrick Industries (NASDAQ:PATK);
  • NorthStar Asset Mgt (NSAM);
  • Northstar Rlty Fin (NRF);
  • Barracuda Netw (NYSE:CUDA);
  • Salesforce Com (NYSE:CRM), and;
  • Best Buy Co (NYSE:BBY).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Synageva BioPharma (NASDAQ:GEVA).

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Baker Felix DIR,BO Synageva Biopharma GEVA JB* $94,190,000
2 Spo Advisory BO Oasis Petroleum OAS B $32,526,500
3 Halldin Anders Ture DIR,BO Vaccinogen VGEN JB* $5,140,190
4 North Tide Capital BO Vivus VVUS B $1,561,341
5 Second Curve Cap BO Regional Mgt RM B $625,600
6 Cascade Inv BO Wac Inf-linked Opp WIW B $283,443
7 Nokomis Capital BO Widepoint WYY B $260,083
8 Frost Phillip Md CEO,CB,BO Opko Health OPK B $223,718
9 Gould Investors BO Brt Realty Trust BRT JB*,B $124,438
10 Eberwein Jeffrey DIR,BO Crossroads Sys CRDS JB* $26,362

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes:
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Schulze Richard BO Best Buy Co BBY AS $62,205,660
2 Jana Partners BO Supervalu SVU S $43,403,700
3 Tylis Albert PR Northstar Asset Mgt NSAM AS $8,998,642
4 Tylis Albert PR Northstar Rlty Fin NRF AS $7,526,724
5 Drako Dean M BO Barracuda Netw CUDA S $4,732,849
6 Gendell Jeffrey L BO Patrick Industries PATK JS* $4,385,000
7 Levow Zachary S DIR Barracuda Netw CUDA AS $3,895,928
8 Steelhead Partners O Resolute Forest RFP S $3,571,271
9 Spinner Steven CEO,DIR United Natural Foods UNFI S $1,681,557
10 Benioff Marc CB,CEO Salesforce Com CRM AS $1,455,946

InsiderInsights.com | Key to Insider Title and Trans Type Codes:
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

If you're interested in the insider history of a stock not shown here, you can search by ticker.

Did you miss our Previous Daily Round Up?

Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.